Skip to content

Manual Cervical Distraction: Measuring Chiropractic Delivery for Neck Pain Clinical Trial

Cervical Distraction Minimal Intervention Development: Translating From Basic to Clinical Studies

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01765751
Acronym
MCD
Enrollment
48
Registered
2013-01-10
Start date
2013-01-31
Completion date
2013-10-31
Last updated
2018-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neck Pain, Pain in Arm, Unspecified

Keywords

Cervical pain, Neck pain, Arm pain

Brief summary

The purpose of the Manual Cervical Distraction: Measuring Chiropractic Delivery for Neck Pain Clinical Trial is to examine the patient-centered clinical and biomechanical outcomes, doctor treatment delivery, and believability characteristics of a commonly used chiropractic procedure for the treatment of neck- or neck-related arm pain or disability.

Detailed description

The purpose of the Manual Cervical Distraction (MCD): Measuring Chiropractic Delivery for Neck Pain Clinical Trial is to examine the patient-centered clinical and biomechanical outcomes, and believability characteristics of a manually-localized cervical distraction procedure for the treatment of neck- or neck-related arm pain or disability. One challenging issue in the study of manual therapies, including spinal manipulation (SM), is the development of sham and/or minimal intervention procedures suitable for use with control groups in clinical trials. With SM, active treatment requires substantial physical contact between a study clinician and the study participant, either directly or through a mechanical intermediary. Consequently, it is difficult to introduce differences in manual therapy procedures that distinguish sham and/or minimal interventions from the active treatment, but are not immediately obvious to the study participant. Another challenging issue is training clinicians to deliver a standardized SM treatment within specified force ranges. The muscles surrounding the neck could alter the forces transmitted to the cervical spine, and could alter the treatment effectiveness. The purpose of this pilot randomized controlled trial is to examine the patient-centered clinical, biomechanical, and believability outcome characteristics of a manually-localized cervical distraction procedure for the treatment of neck or neck-related arm pain or disability. We also will evaluate the ability of the doctor of chiropractic to deliver the MCD treatment within specified force ranges. An exploratory aim of this study is to evaluate EMG measurement during MCD delivery.

Interventions

PROCEDUREManual Cervical Distraction

Manual Cervical Distraction (MCD) is a form of Low Velocity Variable Amplitude Spinal Manipulation (LVVA-SM). MCD procedure is performed with participant lying prone on a load instrumented table with moveable headpiece allowing guided head movement while recumbent. Clinician gently grasps posterior aspect of participant's neck with a broad contact (contact hand) between thumb and index finger at specific vertebral level. With opposite hand, clinician grasps control handle. Using contact hand, clinician exhibits superior traction to maintain a contact at a single vertebral level and ensuring a gentle movement via contact with control handle. Goal is to create a slow rhythmic (1-3 sec) localized distractive movement. In this trial, only axial distraction (Cox protocol 1) will be used.

Sponsors

Loyola University
CollaboratorOTHER
Palmer College of Chiropractic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Age 18 to 70 years (inclusive). * Mechanical neck pain or neck-related upper extremity pain lasting at least 4 weeks duration. * Mechanical neck pain or neck-related upper extremity pain classified as Quebec Task Force (QTF) 2-4. * Naïve to flexion-distraction manual therapy procedures to cervical area. * Average neck pain in the past 24 hours rated between 3 and 7 on a 0-10 Pain Numerical Rating Scale (NRS) at Phone Screen and Baseline 1 Interview. * Signed Informed Consent Document.

Exclusion criteria

* Doctor of chiropractic or current or former chiropractic student. * Average neck pain in past 24 hours rated 0-2 or 8-10 on a 0-10 Pain NRS at Phone Screen and Baseline 1 Interview. * Neck pain from other than somatic tissues as determined by history and clinical examination. * Surgery to cervical-thoracic area within the past 6 months. * Recent fracture in the cervico-thoracic spine or ribs within the past 8 weeks. * Injections for pain in neck, shoulders, arms or hands in the past 4 weeks. * Neck pain classified as QTF 1, 5-11. * Unwillingness to postpone use of all types of manual treatment for neck pain, except those provided in the study for the duration of the study. * Inability or unwillingness to comply with study protocols. * Bone or joint pathologies representing a contraindication to study procedures. * Any single or multisegmental fusion (surgical or congenital) of the 1st through the 7th cervical vertebrae. * Other safety concerns as determined by the clinical evaluation/opinion at case review. * Unable to tolerate study procedures. * Uncontrolled hypertension: systolic blood pressure ≥160 mmHg or diastolic blood pressure ≥100 mmHg. * Simultaneous clinical management for a health condition that compromises ability to deliver study treatment or assess health status. * Inability to read or verbally comprehend English. * Drug or alcohol abuse or dependence, suspected or confirmed through self-report questionnaires and clinical interview. * Depression rated as ≥ 29 on the Beck Depression Inventory. * Cognitive or memory impairment identified during eligibility exam. * Pregnancy, under either of the following 2 circumstances: 1) Participant safety, if participant is unable to tolerate or undergo study procedures; or 2) Fetus safety, if x-rays are required for diagnosis. * Weight greater than 300 lbs (table weight limit). * Referral for evaluation, diagnosis, or management of other health conditions, or additional diagnostics required for neck pain diagnosis. * Retention of legal advice or seeking a health-related insurance claim. * Household member previously enrolled in MCD Clinical Trial. * Compliance concerns identified during baseline eligibility process.

Design outcomes

Primary

MeasureTime frameDescription
Range of Traction ForcesDay 1, 4, 8, 11, 14 (Each Study Visit)We will evaluate the clinician's ability to deliver three randomly assigned manual interventions to the cervical spine within specified traction force ranges (\<20 Newtons \[N\], 20-50N, \>50N). The primary outcome of this study is to determine the accuracy and consistency of traction force delivery ranges both between clinicians and within individual clinicians. Traction force ranges (C5 contact level and Occiput contact level) will be measured at each study visit (visits 1, 2, 3, 4, 5) for 2 weeks and averaged to calculate final outcome.

Secondary

MeasureTime frameDescription
Neck Disability Index (NDI)Change from Baseline to Day 1 (Study Visit 1) and Day 14 (Study Visit 5)The NDI is a 10-item questionnaire modified from the Oswestry Low Back Pain Disability Index. The NDI has been shown to be a reliable and valid measure of disability due to neck pain, and responsive for measuring change. Study Visit 1 and Study Visit 5 Measures occur 2 weeks apart. The NDI scale is measured on a scale of 0-50, with 0 indicating no disability and 50 indicating complete disability. This measure is an adjusted mean NDI change.
Neck Pain Visual Analogue Scale (VAS)Change from Baseline, Day 1, 4, 8, 11, 14 (Pre- and Post-Study Visits 1, 2, 3, 4, 5)The VAS has excellent metric properties, is easy to administer and score (0-100mm), and is commonly used in pain research. Our anchors will be no pain (score of 0) to worst pain imaginable (score of 100). We will ask participants to rate their current neck pain at baseline and pre-/post-treatment for all 5 study visits. This measure is adjusted mean neck pain VAS change. A single value was calculated by averaging.
Patient Reported Outcomes Measurement Information System (PROMIS-43)Change from Baseline to Day 14 (Study Visit 5)The PROMIS-43 questionnaire will be used to measure general functional health status. PROMIS-43 questions measure physical function, anxiety, depression, fatigue, sleep disturbance, social role satisfaction, and pain interference and intensity. The table below displays the mean score at baseline. On the T-score metric & interpretation: * A score of 40 is one SD lower than the mean of the reference population (REF POP). * A score of 60 is one SD higher than the mean of the REF POP. * For PROMIS measures, higher scores equals more of the concept being measured (e.g., more Fatigue, more Physical Function). Thus a score of 60 is one SD above the average REF POP. This could be a desirable or undesirable outcome, depending upon the concept being measured. For Physical Function and Satisfaction with Social Role, higher scores reflect a better outcome, while for the remaining concepts, higher scores reflect a worse outcome. PROMIS - Pain Interference adjusted for baseline neck pain VAS.
Procedure Believability QuestionnaireBaseline (BL), Day 1 (Study Visit 1/T1), Day 14 (Study Visit 5/T5)We will ask all participants whether they feel the study procedure would relieve their neck pain using the Procedure Believability Questionnaire. The response choices will be: Strongly believe the procedure will relieve my neck pain; Somewhat believe the procedure will relieve my neck pain; Somewhat believe the procedure will NOT relieve my neck pain; Strongly believe the procedure will NOT relieve my neck pain; and Don't know if the procedure will relieve my neck pain. A baseline (BL) evaluation will be completed based upon treatment description, and compared to assessments following study visit 1 (T1) and study visit 5 (T5) over a 2-week time period.
Credibility and Expectancy Questionnaire (CEQ)Baseline, Day 1 (Study Visit 1), Day 14 (Study Visit 5)The CEQ is a quick and easy-to-administer questionnaire for measuring treatment expectancy and rationale credibility of interventions for use in clinical outcome studies. Participants' perceptions of the study treatments were compared across groups using the CEQ. The CEQ credibility factor relates to how logical or believable a treatment is for the patient, whereas the expectancy factor refers to the patient's beliefs about improvements that might be achieved from the treatment \[61\]. CEQ scores for both the credibility and expectancy factors range from 3 to 27, with higher scores indicating greater belief in treatment credibility or expectancy for clinical improvement.
Cervical Range of Motion (cROM).Change from Day 1 (Study Visit 1) to Day 14 (Study Visit 5)Cervical ranges of motion are a measure of functional status and can be used to assess dysfunction in the cervical spine. Baseline/visit 1 (BL) cROM is displayed for Flexion-Extension, Lateral Bending, and Rotation. The mean change in cROM from visit 1 to visit 5 (V5 change) is also displayed.

Other

MeasureTime frameDescription
Cervical Muscle Electromyographic (EMG) ActivityDay 8 (Study Visit 3), Day 11 (Study Visit 4)We will describe electromyographic (EMG) activity of superficial neck muscles during delivery of the three manual interventions during visits 3 and 4. EMG measurements are an exploratory outcome variable in this study. RMS EMG TREATMENT DESCRIPTIONS: * (A) Ratio of Root Mean square (RMS) EMG during Treatment at C5/RMS EMG during maximum voluntary contraction (MVC) * (B) RMS EMG during Treatment at C5/RMS EMG during Prone Resting * (C) RMS EMG during Treatment at Occiput (OCC)/RMS EMG during MVC * (D) RMS EMG during Treatment at OCC/ RMS EMG during Prone Resting MUSCLES: * LES-Left erector Spinae Muscle * RES-Right Erector Spinae Muscle * LTRPS- Left Trapezius muscle * RTRPS- Right Trapezius Muscle * LSCM- Left Sternocleido Mastoid muscle * RSCM- Right Sternocleido Mastoid Muscle ACRONYM KEY: * RMS-Root Mean Square Value * MVC-Maximum Voluntary Contraction * C5-Cervical vertebrae contact * OCC-Occipital contact * EMG-Electromyographic activity
Patient Satisfaction QuestionnaireDay 14 (Study Visit 5)Participants' satisfaction with study procedures and staff were assessed at Study Visit 5 using standard questions. Participants rated their satisfaction with various elements of the study (e.g., treatments received, clinicians) using a 5 category response from 1 (strongly satisfied) to 5 (strongly dissatisfied) with categories collapsed into satisfied (categories 1 and 2) or not satisfied (categories 3, 4 or 5) for interpretation.

Countries

United States

Participant flow

Participants by arm

ArmCount
Manual Cervical Distraction Low Force
Manual Cervical Distraction (MCD) forces will be limited to less than 20N in the low force group. Dosing for this clinical trial is limited to 3 sets of 5 repetitions with a hand contact on one cervical vertebra of highest clinical importance and 3 sets of 5 repetitions with a hand contact on the occiput.
16
Manual Cervical Distraction Medium Force
Manual Cervical Distraction(MCD) forces will be limited to between 20N-50N in the medium force group. Dosing for this clinical trial is limited to 3 sets of 5 repetitions with a hand contact on one cervical vertebra of highest clinical importance and 3 sets of 5 repetitions with a hand contact on the occiput.
16
Manual Cervical Distraction High Force
Manual Cervical Distraction (MCD) forces will be limited to greater than 50N in the high force group. Dosing for this clinical trial is limited to 3 sets of 5 repetitions with a hand contact on one cervical vertebra of highest clinical importance and 3 sets of 5 repetitions with a hand contact on the occiput.
16
Total48

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyLost to Follow-up021

Baseline characteristics

CharacteristicManual Cervical Distraction Low ForceManual Cervical Distraction Medium ForceManual Cervical Distraction High ForceTotal
Age, Continuous42.2 years
STANDARD_DEVIATION 11.2
47.0 years
STANDARD_DEVIATION 11.4
51.2 years
STANDARD_DEVIATION 13.7
46.8 years
STANDARD_DEVIATION 12.5
Sex: Female, Male
Female
11 Participants12 Participants8 Participants31 Participants
Sex: Female, Male
Male
5 Participants4 Participants8 Participants17 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 160 / 160 / 16
other
Total, other adverse events
6 / 1610 / 1610 / 16
serious
Total, serious adverse events
0 / 160 / 160 / 16

Outcome results

Primary

Range of Traction Forces

We will evaluate the clinician's ability to deliver three randomly assigned manual interventions to the cervical spine within specified traction force ranges (\<20 Newtons \[N\], 20-50N, \>50N). The primary outcome of this study is to determine the accuracy and consistency of traction force delivery ranges both between clinicians and within individual clinicians. Traction force ranges (C5 contact level and Occiput contact level) will be measured at each study visit (visits 1, 2, 3, 4, 5) for 2 weeks and averaged to calculate final outcome.

Time frame: Day 1, 4, 8, 11, 14 (Each Study Visit)

Population: \*Cervical traction forces measured in Newtons (N) over four treatment visits for each participant. We recorded 23 missing values for traction forces due to 9 missing appointments (18 observations) and 5 instances of technical problems in data collection.

ArmMeasureGroupValue (MEAN)Dispersion
MCD Low ForceRange of Traction ForcesC5 Contact Level13.82 Newtons (N)Standard Deviation 5.74
MCD Low ForceRange of Traction ForcesOcciput Contact Level17.19 Newtons (N)Standard Deviation 4.84
MCD Medium ForceRange of Traction ForcesC5 Contact Level38.3 Newtons (N)Standard Deviation 12.12
MCD Medium ForceRange of Traction ForcesOcciput Contact Level42.87 Newtons (N)Standard Deviation 10.4
MCD High ForceRange of Traction ForcesC5 Contact Level65.08 Newtons (N)Standard Deviation 17.7
MCD High ForceRange of Traction ForcesOcciput Contact Level74.06 Newtons (N)Standard Deviation 16.08
Secondary

Cervical Range of Motion (cROM).

Cervical ranges of motion are a measure of functional status and can be used to assess dysfunction in the cervical spine. Baseline/visit 1 (BL) cROM is displayed for Flexion-Extension, Lateral Bending, and Rotation. The mean change in cROM from visit 1 to visit 5 (V5 change) is also displayed.

Time frame: Change from Day 1 (Study Visit 1) to Day 14 (Study Visit 5)

Population: The number analyzed in row differs from overall due to:~1. Data collection issue due to equipment problems.~2. Participants did not show up for data collection.~3. 3 Participants were lost to follow up

ArmMeasureGroupValue (MEAN)Dispersion
MCD Low ForceCervical Range of Motion (cROM).BL - Mean Flexion-Extension70.2 Degrees - Range of MotionStandard Deviation 25.9
MCD Low ForceCervical Range of Motion (cROM).BL - Mean Lateral Bending51.6 Degrees - Range of MotionStandard Deviation 21.1
MCD Low ForceCervical Range of Motion (cROM).BL - Mean Rotation88.5 Degrees - Range of MotionStandard Deviation 25.4
MCD Low ForceCervical Range of Motion (cROM).Mean Change from BL to V5 - Flexion-Extension0.8 Degrees - Range of MotionStandard Deviation 14.9
MCD Low ForceCervical Range of Motion (cROM).Mean Change from BL to V5 - Lateral Bending-4.7 Degrees - Range of MotionStandard Deviation 24.3
MCD Low ForceCervical Range of Motion (cROM).Mean Change from BL to V5 - Rotation2.3 Degrees - Range of MotionStandard Deviation 15.5
MCD Medium ForceCervical Range of Motion (cROM).Mean Change from BL to V5 - Rotation-8.9 Degrees - Range of MotionStandard Deviation 28
MCD Medium ForceCervical Range of Motion (cROM).BL - Mean Flexion-Extension75.4 Degrees - Range of MotionStandard Deviation 32.4
MCD Medium ForceCervical Range of Motion (cROM).Mean Change from BL to V5 - Flexion-Extension6.1 Degrees - Range of MotionStandard Deviation 31.7
MCD Medium ForceCervical Range of Motion (cROM).Mean Change from BL to V5 - Lateral Bending-2.9 Degrees - Range of MotionStandard Deviation 8.7
MCD Medium ForceCervical Range of Motion (cROM).BL - Mean Lateral Bending54.7 Degrees - Range of MotionStandard Deviation 12.1
MCD Medium ForceCervical Range of Motion (cROM).BL - Mean Rotation91.1 Degrees - Range of MotionStandard Deviation 22.8
MCD High ForceCervical Range of Motion (cROM).BL - Mean Lateral Bending49.8 Degrees - Range of MotionStandard Deviation 13.6
MCD High ForceCervical Range of Motion (cROM).BL - Mean Rotation88.5 Degrees - Range of MotionStandard Deviation 19.7
MCD High ForceCervical Range of Motion (cROM).Mean Change from BL to V5 - Rotation-8.1 Degrees - Range of MotionStandard Deviation 37.5
MCD High ForceCervical Range of Motion (cROM).Mean Change from BL to V5 - Flexion-Extension4.9 Degrees - Range of MotionStandard Deviation 25.2
MCD High ForceCervical Range of Motion (cROM).BL - Mean Flexion-Extension78.6 Degrees - Range of MotionStandard Deviation 28.5
MCD High ForceCervical Range of Motion (cROM).Mean Change from BL to V5 - Lateral Bending-2.3 Degrees - Range of MotionStandard Deviation 24.1
Secondary

Credibility and Expectancy Questionnaire (CEQ)

The CEQ is a quick and easy-to-administer questionnaire for measuring treatment expectancy and rationale credibility of interventions for use in clinical outcome studies. Participants' perceptions of the study treatments were compared across groups using the CEQ. The CEQ credibility factor relates to how logical or believable a treatment is for the patient, whereas the expectancy factor refers to the patient's beliefs about improvements that might be achieved from the treatment \[61\]. CEQ scores for both the credibility and expectancy factors range from 3 to 27, with higher scores indicating greater belief in treatment credibility or expectancy for clinical improvement.

Time frame: Baseline, Day 1 (Study Visit 1), Day 14 (Study Visit 5)

ArmMeasureGroupValue (MEAN)Dispersion
MCD Low ForceCredibility and Expectancy Questionnaire (CEQ)Credibility Factor - Basline 1 Visit19.8 units on a scale (range 3-27)Standard Deviation 2.2
MCD Low ForceCredibility and Expectancy Questionnaire (CEQ)Credibility Factor - Study Visit 115.5 units on a scale (range 3-27)Standard Deviation 7
MCD Low ForceCredibility and Expectancy Questionnaire (CEQ)Credibility Factor - Study Visit 513.8 units on a scale (range 3-27)Standard Deviation 8
MCD Low ForceCredibility and Expectancy Questionnaire (CEQ)Expectancy Factor - Baseline Visit 115.8 units on a scale (range 3-27)Standard Deviation 4
MCD Low ForceCredibility and Expectancy Questionnaire (CEQ)Expectancy Factor - Study Visit 113.4 units on a scale (range 3-27)Standard Deviation 6.2
MCD Low ForceCredibility and Expectancy Questionnaire (CEQ)Expectancy Factor - Study Visit 511.4 units on a scale (range 3-27)Standard Deviation 7.8
MCD Medium ForceCredibility and Expectancy Questionnaire (CEQ)Expectancy Factor - Study Visit 515.1 units on a scale (range 3-27)Standard Deviation 8.3
MCD Medium ForceCredibility and Expectancy Questionnaire (CEQ)Credibility Factor - Basline 1 Visit23.1 units on a scale (range 3-27)Standard Deviation 3.4
MCD Medium ForceCredibility and Expectancy Questionnaire (CEQ)Expectancy Factor - Baseline Visit 119.7 units on a scale (range 3-27)Standard Deviation 4.7
MCD Medium ForceCredibility and Expectancy Questionnaire (CEQ)Expectancy Factor - Study Visit 117.8 units on a scale (range 3-27)Standard Deviation 5.8
MCD Medium ForceCredibility and Expectancy Questionnaire (CEQ)Credibility Factor - Study Visit 119.9 units on a scale (range 3-27)Standard Deviation 5.2
MCD Medium ForceCredibility and Expectancy Questionnaire (CEQ)Credibility Factor - Study Visit 519.9 units on a scale (range 3-27)Standard Deviation 7.5
MCD High ForceCredibility and Expectancy Questionnaire (CEQ)Credibility Factor - Study Visit 122.1 units on a scale (range 3-27)Standard Deviation 4.8
MCD High ForceCredibility and Expectancy Questionnaire (CEQ)Credibility Factor - Study Visit 522.7 units on a scale (range 3-27)Standard Deviation 4
MCD High ForceCredibility and Expectancy Questionnaire (CEQ)Expectancy Factor - Study Visit 517.8 units on a scale (range 3-27)Standard Deviation 6.2
MCD High ForceCredibility and Expectancy Questionnaire (CEQ)Expectancy Factor - Baseline Visit 116.0 units on a scale (range 3-27)Standard Deviation 6.9
MCD High ForceCredibility and Expectancy Questionnaire (CEQ)Credibility Factor - Basline 1 Visit21.0 units on a scale (range 3-27)Standard Deviation 3.9
MCD High ForceCredibility and Expectancy Questionnaire (CEQ)Expectancy Factor - Study Visit 119.3 units on a scale (range 3-27)Standard Deviation 6.7
Secondary

Neck Disability Index (NDI)

The NDI is a 10-item questionnaire modified from the Oswestry Low Back Pain Disability Index. The NDI has been shown to be a reliable and valid measure of disability due to neck pain, and responsive for measuring change. Study Visit 1 and Study Visit 5 Measures occur 2 weeks apart. The NDI scale is measured on a scale of 0-50, with 0 indicating no disability and 50 indicating complete disability. This measure is an adjusted mean NDI change.

Time frame: Change from Baseline to Day 1 (Study Visit 1) and Day 14 (Study Visit 5)

ArmMeasureValue (MEAN)
MCD Low ForceNeck Disability Index (NDI)1.3 units on scale
MCD Medium ForceNeck Disability Index (NDI)4.2 units on scale
MCD High ForceNeck Disability Index (NDI)4.0 units on scale
95% CI: [-0.1, 5.6]
95% CI: [0.1, 5.9]
95% CI: [-3.2, 2.7]
Secondary

Neck Pain Visual Analogue Scale (VAS)

The VAS has excellent metric properties, is easy to administer and score (0-100mm), and is commonly used in pain research. Our anchors will be no pain (score of 0) to worst pain imaginable (score of 100). We will ask participants to rate their current neck pain at baseline and pre-/post-treatment for all 5 study visits. This measure is adjusted mean neck pain VAS change. A single value was calculated by averaging.

Time frame: Change from Baseline, Day 1, 4, 8, 11, 14 (Pre- and Post-Study Visits 1, 2, 3, 4, 5)

ArmMeasureValue (MEAN)
MCD Low ForceNeck Pain Visual Analogue Scale (VAS)9.1 mm
MCD Medium ForceNeck Pain Visual Analogue Scale (VAS)18.9 mm
MCD High ForceNeck Pain Visual Analogue Scale (VAS)24.7 mm
95% CI: [1.6, 29.7]
95% CI: [-3.7, 23.3]
95% CI: [-8.6, 20.3]
Secondary

Patient Reported Outcomes Measurement Information System (PROMIS-43)

The PROMIS-43 questionnaire will be used to measure general functional health status. PROMIS-43 questions measure physical function, anxiety, depression, fatigue, sleep disturbance, social role satisfaction, and pain interference and intensity. The table below displays the mean score at baseline. On the T-score metric & interpretation: * A score of 40 is one SD lower than the mean of the reference population (REF POP). * A score of 60 is one SD higher than the mean of the REF POP. * For PROMIS measures, higher scores equals more of the concept being measured (e.g., more Fatigue, more Physical Function). Thus a score of 60 is one SD above the average REF POP. This could be a desirable or undesirable outcome, depending upon the concept being measured. For Physical Function and Satisfaction with Social Role, higher scores reflect a better outcome, while for the remaining concepts, higher scores reflect a worse outcome. PROMIS - Pain Interference adjusted for baseline neck pain VAS.

Time frame: Change from Baseline to Day 14 (Study Visit 5)

ArmMeasureGroupValue (MEAN)Dispersion
MCD Low ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Anxiety (Day 14)45.3 T-scoreStandard Deviation 9.8
MCD Low ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Fatigue (baseline)50.4 T-scoreStandard Deviation 10.9
MCD Low ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Satisfaction with Social Role (baseline)51.7 T-scoreStandard Deviation 8.5
MCD Low ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Anxiety (baseline)46.8 T-scoreStandard Deviation 10.9
MCD Low ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Fatigue (Day 14)53.8 T-scoreStandard Deviation 12.6
MCD Low ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Pain Interference (Day 14)50.0 T-scoreStandard Deviation 8.4
MCD Low ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Sleep Disturbance (Day 14)51.2 T-scoreStandard Deviation 2.6
MCD Low ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Sleep Disturbance (baseline)51.3 T-scoreStandard Deviation 3
MCD Low ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Depression (Day 14)42.8 T-scoreStandard Deviation 6.3
MCD Low ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Physical Function (baseline)27.7 T-scoreStandard Deviation 5.2
MCD Low ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Pain Interference (baseline)53.2 T-scoreStandard Deviation 6.7
MCD Low ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Depression (baseline)42.6 T-scoreStandard Deviation 6.8
MCD Low ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Physical Function (Day 14)27.2 T-scoreStandard Deviation 6.3
MCD Low ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Satisfaction with Social Role (Day 14)50.9 T-scoreStandard Deviation 11.2
MCD Medium ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Sleep Disturbance (baseline)51.3 T-scoreStandard Deviation 3
MCD Medium ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Pain Interference (baseline)54.9 T-scoreStandard Deviation 5.2
MCD Medium ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Pain Interference (Day 14)49.6 T-scoreStandard Deviation 7.5
MCD Medium ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Physical Function (baseline)25.3 T-scoreStandard Deviation 5
MCD Medium ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Physical Function (Day 14)25.7 T-scoreStandard Deviation 4.8
MCD Medium ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Fatigue (baseline)46.4 T-scoreStandard Deviation 9.3
MCD Medium ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Fatigue (Day 14)47.0 T-scoreStandard Deviation 6.4
MCD Medium ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Anxiety (baseline)47.5 T-scoreStandard Deviation 8
MCD Medium ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Anxiety (Day 14)46.2 T-scoreStandard Deviation 7.2
MCD Medium ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Depression (baseline)43.9 T-scoreStandard Deviation 7.8
MCD Medium ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Depression (Day 14)42.1 T-scoreStandard Deviation 5.6
MCD Medium ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Satisfaction with Social Role (baseline)53.6 T-scoreStandard Deviation 7.6
MCD Medium ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Satisfaction with Social Role (Day 14)55.2 T-scoreStandard Deviation 8
MCD Medium ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Sleep Disturbance (Day 14)52.6 T-scoreStandard Deviation 4.1
MCD High ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Physical Function (baseline)26.4 T-scoreStandard Deviation 4.5
MCD High ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Sleep Disturbance (baseline)51.5 T-scoreStandard Deviation 2.6
MCD High ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Depression (baseline)43.6 T-scoreStandard Deviation 5.5
MCD High ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Pain Interference (Day 14)51.6 T-scoreStandard Deviation 4.9
MCD High ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Sleep Disturbance (Day 14)49.8 T-scoreStandard Deviation 2.4
MCD High ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Depression (Day 14)40.4 T-scoreStandard Deviation 4.6
MCD High ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Pain Interference (baseline)51.2 T-scoreStandard Deviation 5.6
MCD High ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Fatigue (Day 14)45.6 T-scoreStandard Deviation 7.4
MCD High ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Fatigue (baseline)47.1 T-scoreStandard Deviation 7.2
MCD High ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Satisfaction with Social Role (Day 14)53.4 T-scoreStandard Deviation 8.5
MCD High ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Anxiety (baseline)45.3 T-scoreStandard Deviation 8.4
MCD High ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Physical Function (Day 14)25.8 T-scoreStandard Deviation 3.7
MCD High ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Satisfaction with Social Role (baseline)54.3 T-scoreStandard Deviation 6.5
MCD High ForcePatient Reported Outcomes Measurement Information System (PROMIS-43)PROMIS - Anxiety (Day 14)43.4 T-scoreStandard Deviation 5.8
Comparison: Pain Interference95% CI: [-8.1, 0.4]
Comparison: Pain Interference95% CI: [-2.6, 5.6]
Comparison: Pain Interference95% CI: [-9.8, 1]
Comparison: Physical Function95% CI: [-2.2, 3.8]
Comparison: Physical Funtion95% CI: [-2.9, 3.2]
Comparison: Physical Function95% CI: [-2.4, 3.7]
Comparison: Fatigue95% CI: [1.1, 10.5]
Comparison: Fatigue95% CI: [-1.5, 8.2]
Comparison: Fatigue95% CI: [-2.3, 7.3]
Comparison: Sleep Disturbance95% CI: [-0.9, 3.5]
Comparison: Sleep Disturbance95% CI: [-3.6, 0.9]
Comparison: Sleep Disturbance95% CI: [0.4, 5]
Comparison: Anxiety95% CI: [-4.5, 3.9]
Comparison: Anxiety95% CI: [-2.9, 5.1]
Comparison: Anxiety95% CI: [-5.7, 2.9]
Comparison: Depression95% CI: [-6.7, 0.6]
Comparison: Depression95% CI: [-4.1, 2.6]
Comparison: Depression95% CI: [-5.4, 1.4]
Comparison: Satisfaction with Social Role95% CI: [-4.5, 4.9]
Comparison: Satisfaction with Social Role95% CI: [-1.8, 7.7]
Comparison: Satisfaction with Social Role95% CI: [-7.6, 2]
Secondary

Procedure Believability Questionnaire

We will ask all participants whether they feel the study procedure would relieve their neck pain using the Procedure Believability Questionnaire. The response choices will be: Strongly believe the procedure will relieve my neck pain; Somewhat believe the procedure will relieve my neck pain; Somewhat believe the procedure will NOT relieve my neck pain; Strongly believe the procedure will NOT relieve my neck pain; and Don't know if the procedure will relieve my neck pain. A baseline (BL) evaluation will be completed based upon treatment description, and compared to assessments following study visit 1 (T1) and study visit 5 (T5) over a 2-week time period.

Time frame: Baseline (BL), Day 1 (Study Visit 1/T1), Day 14 (Study Visit 5/T5)

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
MCD Low ForceProcedure Believability QuestionnaireBL - Strongly will NOT0 Participants
MCD Low ForceProcedure Believability QuestionnaireT5 - Somewhat WILL4 Participants
MCD Low ForceProcedure Believability QuestionnaireT5 - Somewhat will not1 Participants
MCD Low ForceProcedure Believability QuestionnaireBL - Somewhat WILL5 Participants
MCD Low ForceProcedure Believability QuestionnaireT5 - Strongly will NOT6 Participants
MCD Low ForceProcedure Believability QuestionnaireBL - Don't know8 Participants
MCD Low ForceProcedure Believability QuestionnaireT5 - Don't know1 Participants
MCD Low ForceProcedure Believability QuestionnaireT5 - Missing0 Participants
MCD Low ForceProcedure Believability QuestionnaireT1 - Strongly WILL4 Participants
MCD Low ForceProcedure Believability QuestionnaireT1 - Somewhat WILL6 Participants
MCD Low ForceProcedure Believability QuestionnaireBL - Somewhat will not0 Participants
MCD Low ForceProcedure Believability QuestionnaireT1 - Somewhat will not2 Participants
MCD Low ForceProcedure Believability QuestionnaireT1 - Strongly will NOT1 Participants
MCD Low ForceProcedure Believability QuestionnaireT1 - Don't know3 Participants
MCD Low ForceProcedure Believability QuestionnaireBL - Strongly WILL3 Participants
MCD Low ForceProcedure Believability QuestionnaireT5 - Strongly WILL4 Participants
MCD Medium ForceProcedure Believability QuestionnaireT1 - Don't know0 Participants
MCD Medium ForceProcedure Believability QuestionnaireT1 - Strongly WILL6 Participants
MCD Medium ForceProcedure Believability QuestionnaireT5 - Somewhat WILL8 Participants
MCD Medium ForceProcedure Believability QuestionnaireBL - Strongly will NOT0 Participants
MCD Medium ForceProcedure Believability QuestionnaireBL - Strongly WILL6 Participants
MCD Medium ForceProcedure Believability QuestionnaireT5 - Somewhat will not2 Participants
MCD Medium ForceProcedure Believability QuestionnaireT1 - Strongly will NOT0 Participants
MCD Medium ForceProcedure Believability QuestionnaireT1 - Somewhat WILL10 Participants
MCD Medium ForceProcedure Believability QuestionnaireT5 - Strongly will NOT0 Participants
MCD Medium ForceProcedure Believability QuestionnaireBL - Somewhat will not1 Participants
MCD Medium ForceProcedure Believability QuestionnaireT5 - Strongly WILL5 Participants
MCD Medium ForceProcedure Believability QuestionnaireT5 - Don't know0 Participants
MCD Medium ForceProcedure Believability QuestionnaireBL - Don't know4 Participants
MCD Medium ForceProcedure Believability QuestionnaireT1 - Somewhat will not0 Participants
MCD Medium ForceProcedure Believability QuestionnaireT5 - Missing1 Participants
MCD Medium ForceProcedure Believability QuestionnaireBL - Somewhat WILL5 Participants
MCD High ForceProcedure Believability QuestionnaireT5 - Missing2 Participants
MCD High ForceProcedure Believability QuestionnaireBL - Strongly WILL3 Participants
MCD High ForceProcedure Believability QuestionnaireBL - Somewhat WILL8 Participants
MCD High ForceProcedure Believability QuestionnaireBL - Somewhat will not0 Participants
MCD High ForceProcedure Believability QuestionnaireBL - Strongly will NOT4 Participants
MCD High ForceProcedure Believability QuestionnaireBL - Don't know4 Participants
MCD High ForceProcedure Believability QuestionnaireT1 - Strongly WILL4 Participants
MCD High ForceProcedure Believability QuestionnaireT1 - Somewhat WILL8 Participants
MCD High ForceProcedure Believability QuestionnaireT1 - Strongly will NOT1 Participants
MCD High ForceProcedure Believability QuestionnaireT1 - Don't know3 Participants
MCD High ForceProcedure Believability QuestionnaireT5 - Strongly WILL3 Participants
MCD High ForceProcedure Believability QuestionnaireT5 - Somewhat WILL6 Participants
MCD High ForceProcedure Believability QuestionnaireT5 - Somewhat will not0 Participants
MCD High ForceProcedure Believability QuestionnaireT5 - Strongly will NOT2 Participants
MCD High ForceProcedure Believability QuestionnaireT5 - Don't know3 Participants
MCD High ForceProcedure Believability QuestionnaireT1 - Somewhat will not0 Participants
Other Pre-specified

Cervical Muscle Electromyographic (EMG) Activity

We will describe electromyographic (EMG) activity of superficial neck muscles during delivery of the three manual interventions during visits 3 and 4. EMG measurements are an exploratory outcome variable in this study. RMS EMG TREATMENT DESCRIPTIONS: * (A) Ratio of Root Mean square (RMS) EMG during Treatment at C5/RMS EMG during maximum voluntary contraction (MVC) * (B) RMS EMG during Treatment at C5/RMS EMG during Prone Resting * (C) RMS EMG during Treatment at Occiput (OCC)/RMS EMG during MVC * (D) RMS EMG during Treatment at OCC/ RMS EMG during Prone Resting MUSCLES: * LES-Left erector Spinae Muscle * RES-Right Erector Spinae Muscle * LTRPS- Left Trapezius muscle * RTRPS- Right Trapezius Muscle * LSCM- Left Sternocleido Mastoid muscle * RSCM- Right Sternocleido Mastoid Muscle ACRONYM KEY: * RMS-Root Mean Square Value * MVC-Maximum Voluntary Contraction * C5-Cervical vertebrae contact * OCC-Occipital contact * EMG-Electromyographic activity

Time frame: Day 8 (Study Visit 3), Day 11 (Study Visit 4)

Population: The numbers analyzed in the row differ from the overall due to: (1) Data not collected due to technical problems, (2) Patient did not show up for the visit, (3) 3 participants lost to follow up.

ArmMeasureGroupValue (MEAN)Dispersion
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (C) - LSCM0.12 ratioStandard Deviation 0.15
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (A) - RTRPS0.42 ratioStandard Deviation 0.3
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (B) - RTRPS1.61 ratioStandard Deviation 1.21
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (B) - RSCM1.47 ratioStandard Deviation 0.66
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (B) - LSCM1.29 ratioStandard Deviation 0.38
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (B) - RSCM1.53 ratioStandard Deviation 0.95
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (C) - LES0.27 ratioStandard Deviation 0.15
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (C) - LES0.21 ratioStandard Deviation 0.17
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (C) - RES0.13 ratioStandard Deviation 0.1
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (C) - LTRPS0.23 ratioStandard Deviation 0.21
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (A) - RES0.28 ratioStandard Deviation 0.28
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (C) - RTRPS0.38 ratioStandard Deviation 0.27
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (C) - RES0.25 ratioStandard Deviation 0.22
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (B) - LTRPS1.36 ratioStandard Deviation 0.41
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (C) - RSCM0.19 ratioStandard Deviation 0.17
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (A) - LSCM0.24 ratioStandard Deviation 0.26
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (D) - LES1.29 ratioStandard Deviation 0.54
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (C) - LTRPS0.23 ratioStandard Deviation 0.2
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (D) - RES1.08 ratioStandard Deviation 0.51
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (D) - LTRPS1.48 ratioStandard Deviation 0.74
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (D) - RTRPS1.26 ratioStandard Deviation 0.5
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (C) - RTRPS0.36 ratioStandard Deviation 0.29
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (D) - LSCM1.65 ratioStandard Deviation 1.73
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (D) - RSCM1.31 ratioStandard Deviation 0.44
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (C) - LSCM0.24 ratioStandard Deviation 0.24
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (A) - RSCM0.15 ratioStandard Deviation 0.07
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (C) - RSCM0.13 ratioStandard Deviation 0.07
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (D) - LES1.41 ratioStandard Deviation 0.95
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (D) - RES1.77 ratioStandard Deviation 1.43
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (B) - LES1.32 ratioStandard Deviation 1.04
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (D) - LTRPS1.38 ratioStandard Deviation 0.57
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (D) - RTRPS1.68 ratioStandard Deviation 1.72
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (A) - LTRPS0.27 ratioStandard Deviation 0.25
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (D) - LSCM1.30 ratioStandard Deviation 0.26
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (B) - RES1.67 ratioStandard Deviation 0.92
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (D) - RSCM1.32 ratioStandard Deviation 0.34
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (A) - LES0.30 ratioStandard Deviation 0.15
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (A) - RES0.20 ratioStandard Deviation 0.18
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (B) - LTRPS1.41 ratioStandard Deviation 0.44
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (A) - LTRPS0.24 ratioStandard Deviation 0.23
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (A) - RTRPS0.43 ratioStandard Deviation 0.27
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (B) - RTRPS1.29 ratioStandard Deviation 0.18
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (A) - LSCM0.11 ratioStandard Deviation 0.09
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (A) - RSCM0.22 ratioStandard Deviation 0.19
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (A) - LES0.25 ratioStandard Deviation 0.2
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (B) - LES1.34 ratioStandard Deviation 0.83
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (B) - LSCM1.36 ratioStandard Deviation 0.5
MCD Low ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (B) - RES2.17 ratioStandard Deviation 2.2
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (B) - LSCM1.68 ratioStandard Deviation 1.27
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (B) - LTRPS1.31 ratioStandard Deviation 0.19
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (C) - LSCM0.15 ratioStandard Deviation 0.15
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (A) - LES0.25 ratioStandard Deviation 0.15
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (B) - RTRPS1.14 ratioStandard Deviation 0.38
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (A) - LTRPS0.23 ratioStandard Deviation 0.12
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (C) - RSCM0.17 ratioStandard Deviation 0.16
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (B) - LSCM1.82 ratioStandard Deviation 0.97
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (B) - RSCM1.83 ratioStandard Deviation 1.13
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (A) - RSCM0.19 ratioStandard Deviation 0.17
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (B) - RSCM1.55 ratioStandard Deviation 1.15
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (A) - RTRPS0.37 ratioStandard Deviation 0.26
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (A) - LSCM0.27 ratioStandard Deviation 0.22
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (C) - LES0.27 ratioStandard Deviation 0.2
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (D) - LES1.54 ratioStandard Deviation 1.06
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (A) - LES0.26 ratioStandard Deviation 0.22
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (C) - RES0.30 ratioStandard Deviation 0.22
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (C) - LES0.22 ratioStandard Deviation 0.19
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (A) - RES0.28 ratioStandard Deviation 0.17
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (C) - LTRPS0.21 ratioStandard Deviation 0.2
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (D) - RES1.41 ratioStandard Deviation 0.25
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (B) - RTRPS1.31 ratioStandard Deviation 0.22
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (C) - RTRPS0.32 ratioStandard Deviation 0.29
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (B) - LES1.71 ratioStandard Deviation 1.54
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (D) - LTRPS1.47 ratioStandard Deviation 0.6
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (C) - LSCM0.17 ratioStandard Deviation 0.13
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (C) - RES0.24 ratioStandard Deviation 0.15
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (B) - LES2.03 ratioStandard Deviation 1.46
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (C) - RSCM0.22 ratioStandard Deviation 0.24
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (A) - LTRPS0.22 ratioStandard Deviation 0.2
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (D) - RTRPS1.38 ratioStandard Deviation 0.28
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (D) - LES1.68 ratioStandard Deviation 1.12
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (B) - LTRPS1.80 ratioStandard Deviation 0.85
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (A) - RSCM0.18 ratioStandard Deviation 0.22
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (D) - RES1.32 ratioStandard Deviation 0.65
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (C) - LTRPS0.19 ratioStandard Deviation 0.12
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (D) - LSCM1.48 ratioStandard Deviation 0.54
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (D) - LTRPS1.40 ratioStandard Deviation 0.7
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (A) - LSCM0.22 ratioStandard Deviation 0.18
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (A) - RTRPS0.28 ratioStandard Deviation 0.22
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (D) - RTRPS1.36 ratioStandard Deviation 0.42
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (B) - RES2.06 ratioStandard Deviation 0.92
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (D) - RSCM1.48 ratioStandard Deviation 0.43
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (D) - LSCM2.38 ratioStandard Deviation 1.86
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (C) - RTRPS0.36 ratioStandard Deviation 0.26
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (B) - RES2.53 ratioStandard Deviation 2.12
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (D) - RSCM1.54 ratioStandard Deviation 0.63
MCD Medium ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (A) - RES0.34 ratioStandard Deviation 0.14
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (D) - RSCM1.32 ratioStandard Deviation 0.4
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (A) - LES0.31 ratioStandard Deviation 0.25
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (A) - RES0.16 ratioStandard Deviation 0.13
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (A) - LTRPS0.22 ratioStandard Deviation 0.2
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (A) - RTRPS0.29 ratioStandard Deviation 0.25
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (A) - LSCM0.14 ratioStandard Deviation 0.1
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (A) - RSCM0.13 ratioStandard Deviation 0.12
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (B) - LES1.40 ratioStandard Deviation 0.76
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (B) - RES2.13 ratioStandard Deviation 1.78
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (B) - RTRPS1.20 ratioStandard Deviation 0.22
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (B) - LSCM1.78 ratioStandard Deviation 1.4
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (B) - RSCM1.41 ratioStandard Deviation 0.66
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (C) - LES0.25 ratioStandard Deviation 0.19
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (C) - RES0.16 ratioStandard Deviation 0.16
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (C) - LTRPS0.24 ratioStandard Deviation 0.22
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (C) - RTRPS0.31 ratioStandard Deviation 0.29
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (C) - LSCM0.12 ratioStandard Deviation 0.09
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (C) - RSCM0.12 ratioStandard Deviation 0.08
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (D) - LES1.49 ratioStandard Deviation 0.88
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (D) - RES1.58 ratioStandard Deviation 1.38
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (D) - LTRPS1.24 ratioStandard Deviation 0.19
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (D) - RTRPS1.21 ratioStandard Deviation 0.16
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (D) - LSCM1.69 ratioStandard Deviation 0.98
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (D) - RSCM1.49 ratioStandard Deviation 0.75
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (A) - LES0.27 ratioStandard Deviation 0.19
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (A) - RES0.20 ratioStandard Deviation 0.22
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (A) - LTRPS0.25 ratioStandard Deviation 0.24
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (A) - RTRPS0.30 ratioStandard Deviation 0.25
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (A) - LSCM0.13 ratioStandard Deviation 0.09
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (A) - RSCM0.15 ratioStandard Deviation 0.12
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (B) - LES1.75 ratioStandard Deviation 1.5
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (B) - RES1.81 ratioStandard Deviation 1.53
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (B) - LTRPS1.84 ratioStandard Deviation 1.69
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (B) - RTRPS1.27 ratioStandard Deviation 0.13
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (B) - LSCM2.20 ratioStandard Deviation 1.29
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (B) - RSCM1.67 ratioStandard Deviation 0.92
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (C) - LES0.22 ratioStandard Deviation 0.17
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (C) - RES0.15 ratioStandard Deviation 0.17
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (C) - LTRPS0.21 ratioStandard Deviation 0.24
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (C) - RTRPS0.31 ratioStandard Deviation 0.26
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (C) - LSCM0.12 ratioStandard Deviation 0.09
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (C) - RSCM0.14 ratioStandard Deviation 0.17
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (D) - LES1.59 ratioStandard Deviation 1.43
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (D) - RES1.76 ratioStandard Deviation 1.12
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (D) - LTRPS1.49 ratioStandard Deviation 0.56
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (D) - RTRPS1.31 ratioStandard Deviation 0.14
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 4 - (D) - LSCM2.37 ratioStandard Deviation 2.57
MCD High ForceCervical Muscle Electromyographic (EMG) ActivityVisit 3 - (B) - LTRPS1.27 ratioStandard Deviation 0.37
Other Pre-specified

Patient Satisfaction Questionnaire

Participants' satisfaction with study procedures and staff were assessed at Study Visit 5 using standard questions. Participants rated their satisfaction with various elements of the study (e.g., treatments received, clinicians) using a 5 category response from 1 (strongly satisfied) to 5 (strongly dissatisfied) with categories collapsed into satisfied (categories 1 and 2) or not satisfied (categories 3, 4 or 5) for interpretation.

Time frame: Day 14 (Study Visit 5)

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
MCD Low ForcePatient Satisfaction QuestionnaireSatisfied with Treatment7 Participants
MCD Low ForcePatient Satisfaction QuestionnaireSatisfied with Clinician14 Participants
MCD Medium ForcePatient Satisfaction QuestionnaireSatisfied with Treatment9 Participants
MCD Medium ForcePatient Satisfaction QuestionnaireSatisfied with Clinician14 Participants
MCD High ForcePatient Satisfaction QuestionnaireSatisfied with Treatment15 Participants
MCD High ForcePatient Satisfaction QuestionnaireSatisfied with Clinician15 Participants

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026